**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 15663-27-1 |cis-Dichlorodiamineplatinum(II) | 99.99 | 239-733-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 25 36/37/38 42/43 45
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic if swallowed. Irritating to eyes, respiratory system and skin.
May cause sensitization by inhalation and skin contact. May cause
cancer.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May cause skin sensitization, an allergic
reaction, which becomes evident upon re-exposure to this material.
Ingestion:
May be fatal if swallowed.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Potential cancer hazard. May cause adverse reproductive effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
POISON material. If swallowed, get medical aid immediately. Only
induce vomiting if directed to do so by medical personnel. Never give
anything by mouth to an unconscious person.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do not use
mouth-to-mouth resuscitation if victim ingested or inhaled the
substance; induce artificial respiration with the aid of a pocket
mask equipped with a one-way valve or other proper respiratory
medical device.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Use water spray, dry chemical, carbon
dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Do not get in
eyes, on skin, or on clothing. Keep container tightly closed. Do not
ingest or inhale. Use only in a chemical fume hood. Discard
contaminated shoes. Do not breathe dust.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Poison room locked. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower.
Exposure Limits
CAS# 15663-27-1:
United States OSHA: 0.002 mg/m3 TWA (as Pt) (listed under Platin
soluble salts).
Belgium - TWA: (listed as platinum soluble salts): 0.002 mg/m3 VL
(as Pt)
Japan: (listed as platinum soluble salts): 0.001 mg/m3 OEL (as Pt
Malaysia: (listed as platinum soluble salts): 0.002 mg/m3 TWA (as
Netherlands: (listed as platinum soluble salts): 0.002 mg/m3 MAC
Pt)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 270 deg C (decomposition)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 270 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 3.738g/m3
Molecular Formula: Cl2H6N2Pt
Molecular Weight: 300.05
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, ammonia.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 15663-27-1: TP2450000
LD50/LC50:
CAS# 15663-27-1: Oral, mouse: LD50 = 32700 ug/kg; Oral, rat: LD50 =
25800 ug/kg.
Carcinogenicity:
cis-Dichlorodiamineplatinum(II) -
California: carcinogen, initial date 10/1/88
NTP: Suspect carcinogen
IARC: Group 2A carcinogen
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3288
Packing Group: II
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing Group: II
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 45 May cause cancer.
R 25 Toxic if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 42/43 May cause sensitization by inhalation and
skin contact.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 15663-27-1: 3
Canada
CAS# 15663-27-1 is listed on Canada's NDSL List.
CAS# 15663-27-1 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15663-27-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Amino-2-Naphthoic Acid, 90%
| 11668-47-4 |
|
Zirconium (IV) Oxide, P.A.
| 1314-23-4 |
|
cis-Dichlorodiamineplatinum(II), 99.99%
| 15663-27-1 |
|
1-Bromonaphthalene 96%, contains max. 2% 2-bromonaphthalene
| 90-11-9 |
|
1-Heptanesulfonic acid, sodium salt, monohydrate, HPLC grade
| 207300-90-1 |
|
1-Hexanesulfonic acid sodium salt, HPLC grade
| 2832-45-3 |
|
5-Bromo-1-pentene, 96%
| 1119-51-3 |
|
2,6-Diphenylphenol
| 2432-11-3 |
|
L-Cystine
| 56-89-3 |
|
1-Pentanesulfonic Acid, Sodium Salt Monohydrate, HPLC Grade
| 22767-49-3 |
|
1,1,2-Trichloroethane Density Standard
| 79-00-5 |
|
2-Ethoxyethanol, 99%
| 110-80-5 |
|
Antimony Trichloride
| 10025-91-9 |
|
2-Ethoxyethyl acetate 99%
| 111-15-9 |
|
DL-2-Octanol, 97%
| 123-96-6 |
|
2,2,2-Trifluoroethanol
| 75-89-8 |
|
5-Amino-2-methylindole, 98%
| 7570-49-2 |
|
Bromoacetaldehyde Diethyl Acetal, 97%
| 2032-35-1 |
|
2-Acetylcyclohexanone, 97%
| 874-23-7 |
|
Lauric acid, 98%
| 143-07-7 |
|
4-Methoxy-2-nitroaniline, 98%
| 96-96-8 |
|
1-Nitroso-2-naphthol-3,6-disulfonic acid disodium salt
| 0-00-0 |
|
Toluidine Blue O Zinc Chloride Double Salt
| 0-01-1 |
|
2,4,6-Triphenylpyrylium Chloride, 90%
| 40836-01-9 |
|
2-Isopropoxyethanol, 98%
| 109-59-1 |
|
2,6-Difluorobenzoyl Isocyanate
| 60731-73-9 |
|
1-(4-Chlorophenyl)-1-Cyclopropane- Carboxylic Acid, 99%
| 72934-37-3 |
|
1-Bromo-1-propene, mixture of isomers, 95%
| 590-14-7 |
|
3-Aminopyrrolidine Dihydrochloride
| 103831-11-4 |
|
2,2,4-Trimethylpentane, p.a.
| 540-84-1 |
|
Phenyl Salicylate, 99% (UV-Vis)
| 118-55-8 |
|
MOPS
| 1132-61-2 |
|
P-Naphtholbenzein, 90+% (UV-VIS)
| 145-50-6 |
|
1-Amino-4-Hydroxyanthraquinone, 96%
| 116-85-8 |
|
4-Aminoantipyrine, 98%
| 83-07-8 |
|
Sodium metatungstate, 2.82 density solution in water, stabilized
| 7732-18-5 |
|
8-Hydroxyquinoline, p.a.
| 148-24-3 |
|
3-Methyl-2-Cyclohexen-1-One, 98%
| 1193-18-6 |
|
Cerium(IV) sulfate tetrahydrate
| 10294-42-5 |
|
Sodium metatungstate hydrate, crystalline
| 12141-67-2 |
|
O-Methylbenzyl Cyanide, 98%
| 22364-68-7 |
|
l(-)-Glutathione, oxidized, hydrate, 95%
| 27025-41-8 |
|
Antimony Trioxide
| 1309-64-4 |
|
Dibutyl L-Tartrate
| 87-92-3 |
|
(-)-Terpinen-4-ol, 97%
| 562-74-3 |
|
3,5-Dinitrosalicylic Acid Monosodium Salt, Monohydrate, 97% (Titr.)
| 46506-88-1 |
|
4-Tert.-Butyl-Calix[4]arene-Crown-4-Complex
| 171058-95-0 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex
| 99314-01-9 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex
| 129518-51-0 |
|
2,3,4,5-Tetrafluoro-6-nitrobenzoic acid
| 16583-08-7 |
|
|